In this episode, we discuss recently published practice-changing trials RECOVERY and REMAP-CAP. These trials have clearly demonstrated the difference in mortality with the use of Tocilizumab in severe COVID-19.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
